Telomere attrition and diabetes mellitus

Area of Science:

• Endocrinology
• Genetics
• Cell Biology

Background:

• Type 2 diabetes mellitus (DM) involves organ dysfunction and is linked to telomere attrition in leukocytes.
• Oxidative stress in DM patients damages telomeres, shortening their length and potentially serving as a marker for mortality and complications.
• Leukocyte telomere length is also associated with obesity and insulin resistance, common in type 2 DM.

Purpose of the Study:

• To investigate the role of telomere length in pancreatic beta-cells in type 2 diabetes.
• To explore the relationship between telomere attrition in various tissues and the pathophysiology of type 2 DM.
• To identify potential therapeutic targets for preventing type 2 DM progression.

Main Methods:

• Review of recent studies on telomere length and type 2 diabetes.
• Analysis of telomere length in pancreatic beta-cells of DM patients.
• Examination of telomere attrition in adipose tissue using animal models.

Main Results:

• Telomere length is shortened in pancreatic beta-cells of DM patients, impacting proliferation, insulin secretion, and cell survival.
• Telomere attrition in adipose tissue has been shown to induce insulin resistance in animal models.
• A vicious cycle involving hyperglycemia, oxidative stress, and telomere attrition in beta-cells and adipocytes contributes to type 2 DM pathophysiology.

Conclusions:

• Shortened telomeres in pancreatic beta-cells and adipocytes are implicated in type 2 diabetes development and progression.
• Telomere attrition may represent a key mechanism underlying the complex pathophysiology of type 2 DM.
• Inhibiting telomere attrition could offer a novel therapeutic strategy for managing type 2 diabetes and its complications.